Zanamivir (intravenous form) is an antiviral medication used to treat influenza (flu) infections. It works by blocking a protein that helps the flu virus spread within the body. When given through an IV (directly into the vein), this medication can help treat severe cases of flu, particularly in patients who cannot take oral medications. This formulation is especially important for treating complicated flu infections in very young patients, such as newborns and infants under 6 months of age who are sick enough to require hospital care.

Human Influenza – A highly contagious respiratory infection caused by influenza viruses that primarily affects the nose, throat, and lungs. The illness typically develops suddenly with symptoms including fever, muscle aches, fatigue, headache, and respiratory symptoms such as cough and runny nose. The virus spreads through tiny droplets made when infected people cough, sneeze, or talk. Symptoms usually appear within 1-4 days after exposure to the virus and most people recover within a week or two. The severity of symptoms can vary from mild to severe, with young children, elderly people, and those with weakened immune systems being more vulnerable to complications. The virus can cause seasonal epidemics, typically occurring during winter months in temperate regions.